Publications de Patricia MARINO

Marino Patricia, Touzani Rajae, Seguin Lorène, Moulin Jean Francois, Palomares Myriam, Cappiello Maria-Antonietta, Provansal Magali, Vittot Martine, Dermeche Slimane, Launay Simon, Goncalves Anthony, Bouhnik Anne Deborah, Gravis Gwenaelle. Advance Approval of Outpatient Chemotherapy via Phone Call Optimizes Healthcare Delivery without Compromising Patient Satisfaction with Care. Cancers 2021 ; 13 (6) : 1337.
Rodwin Marc A, Mancini Julien, Duran Ségolène, Jalbert Anne-Céline, Viens Patrice, Maraninchi Dominique, Gonçalves Anthony, Marino Patricia. The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004–2017. European Journal of Cancer 2021 ; 145 : 11 - 18.
Pignot Geraldine, Touzani Rajae, Marino Patricia, Walz Jochen, Rybikowski Stanislas, Maubon Thomas, Salem Naji, Mancini Julien, Gravis Gwenaelle, Bendiane Marc Karim, Bouhnik Anne-Déborah. Impact of active surveillance for prostate cancer on the risk of depression and anxiety: Patient-reported outcomes (PROs) from the Vican Prospective Cohort. Journal of Clinical Oncology 2021 ; 39 (6SUPPL) : 220-220.
Seguin Lorène, Touzani Rajae, Bouhnik Anne-Déborah, Charif Ali Ben, Marino Patricia, Bendiane Marc-Karim, Gonçalves Anthony, Gravis Gwenaelle, Mancini Julien. Deterioration of Sexual Health in Cancer Survivors Five Years after Diagnosis: Data from the French National Prospective VICAN Survey. Cancers 2020 ; 12 (11) : 3453.
Coquerelle Séverine, Darlington Meryl, Michel Morgane, Durand Manon, Borget Isabelle, Baffert Sandrine, Marino Patricia, Perrier Lionel, Durand-Zaleski Isabelle. Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments. Value in Health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 ; 23 (7) : pp. 898-906.
Dano Domitille, Hénon Clémence, Sarr Ousseynou, Ka Kanta, Ba Mouhamadou, Badiane Awa, Thiam Ibrahima, Diene Papa, Diop Mamadou, Dem Ahmadou, Marino Patricia, Mancini Julien, Annede Pierre, Gonçalves Anthony, Diouf Doudou, Monneur Audrey. Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study. Journal of Global Oncology 2019 ; 5 (5) : 1-9.
Marino Patricia, Bannier Marie, Moulin Jean-François, Gravis Gwenaëlle. The role and use of Patient Reported Outcomes in the management of cancer patients. Bulletin du Cancer 2018 ; 105 (6) : 603-609.
Marino Patricia, Touzani Rajae, Perrier Lionel, Rouleau Etienne, Kossi Dede Sika, Zhaomin Zou, Charrier Nathanaël, Goardon Nicolas, Preudhomme Claude, Durand-Zaleski Isabelle, Borget Isabelle, Baffert Sandrine, Coppin Lucie, Leclerc Julie, Odou Marie-Francoise. Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study. European Journal of Human Genetics 2018 ; 26 (3) : pp. 314-323.
Kossi Dede Sika, Touzani Rajae, Borget Isabelle, Zou Zhaomin, Vaur Dominique, Rouleau Etienne, Preudhomme Claude, Perrier Lionel, Lacroix Ludovic, Durand-Zaleski Isabelle, Marino Patricia, Baffert Sandrine. Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in France: Next Generation Sequencing. 2016 ; 19 (7) : A693.
Marino Patricia, Teyssier Luis Sagaon, Malavolti Laetitia, Le Corroller-Soriano Anne-Gaëlle. Sex Differences in the Return-to-Work Process of Cancer Survivors 2 Years After Diagnosis: Results From a Large French Population-Based Sample. Journal of Clinical Oncology 2013 ; 31 (10) : 1277-1284.
Marino Patricia, Siani Carole, Bertucci François, Roche Henri, Martin Anne-Laure, Viens Patrice, Seror Valérie. Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients. Breast Cancer Research and Treatment 2010 ; 129 (2) : 401-409.
Marino Patricia, Siani C., Roché H., Protière C., Fumoleau P., Spielmann M., Martin A.-L, Viens P., Le Corroller Soriano A.-. Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic study. Annals of Oncology 2010 ; 21 (7) : 1448-1454.
Marino Patricia, Siani Carole, Roché Henri, Moatti Jean-Paul. Impact of uncertainty on cost-effectiveness analysis of medical strategies: The case of high-dose chemotherapy for breast cancer patients. International Journal of Technology Assessment in Health Care 2005 ; 21 : 342-350.